Risdiplam Oral Solution 60 mg/80 mL – Uses, Benefits, Dosage & FAQs

Risdiplam Oral Solution 60 mg/80 mL contains risdiplam, an oral SMN2 splicing modifier used for the treatment of spinal muscular atrophy (SMA) in pediatric and adult patients. The product is supplied as powder that is constituted to provide 60 mg/80 mL (0.75 mg/mL) oral solution.

Risdiplam Oral Solution 60 mg/80 mL Benefits

Used in the treatment of spinal muscular atrophy (SMA).

Oral administration avoids the need for injection.

Suitable for pediatric and adult patients when prescribed appropriately.

Helps increase production of functional SMN protein by modifying SMN2 RNA splicing.

Can be administered once daily, with or without food, according to the prescribed dose.

Risdiplam Oral Solution Uses

Risdiplam is prescribed for patients with spinal muscular atrophy, a genetic neuromuscular disorder associated with deficiency of survival motor neuron (SMN) protein. Risdiplam works by modifying SMN2 pre-mRNA splicing to increase production of functional SMN protein.

Risdiplam Dosage

The prescribed dose depends on the patient's age and body weight. Current U.S. prescribing information lists:

Under 2 months: 0.15 mg/kg once daily

2 months to under 2 years: 0.2 mg/kg once daily

2 years and older, under 20 kg: 0.25 mg/kg once daily

2 years and older, 20 kg or more: 5 mg once daily

The oral solution should be measured using the supplied oral syringe. The powder must be properly constituted by a healthcare professional before dispensing. Do not change the prescribed dose without medical advice.

Side Effects of Risdiplam

Possible side effects may include:

Fever

Diarrhea

Rash

Upper or lower respiratory tract infection

Constipation

Vomiting

Cough

Side effects can vary depending on the patient's age and clinical condition. Seek medical advice if any unusual or severe symptoms occur.

Storage & Handling

After constitution, Risdiplam oral solution should generally be stored in its original amber bottle and protected from light. The current U.S. labeling recommends refrigeration at 2°C–8°C (36°F–46°F) and states that it should not be frozen. If refrigeration is unavailable, specific room-temperature storage limits apply.

Risdiplam Oral Solution 60 mg/80 mL FAQs

1. What is Risdiplam Oral Solution 60 mg/80 mL?

It is an oral formulation containing risdiplam used for the treatment of spinal muscular atrophy (SMA).

2. What is the strength of Risdiplam Oral Solution?

After constitution, the product provides 60 mg of risdiplam in 80 mL, equivalent to 0.75 mg/mL.

3. What is Risdiplam used for?

Risdiplam is used to treat spinal muscular atrophy in eligible pediatric and adult patients.

4. How is Risdiplam administered?

It is administered orally once daily, with or without food, using the supplied oral syringe.

5. Can Risdiplam be used in children?

Yes. The current prescribing information includes weight- and age-based dosing for pediatric patients.

6. Does Risdiplam require refrigeration?

The constituted solution should preferably be refrigerated at 2°C–8°C and must not be frozen. Follow the product's current storage instructions.

7. Is Risdiplam available as a prescription medicine?

Yes. Risdiplam is a prescription medicine and should be used under the supervision of a qualified healthcare professional.

Important: This information is for educational purposes only and does not replace the prescribing information or advice of a qualified healthcare professional. Availability, approved indications, dosage recommendations, and import requirements may vary by country.